By Katherine Hamilton
Arcus Biosciences named former Amgen executive Richard Markus as its chief medical officer.
The biopharmaceutical company, which is focused on cancer treatments, said Tuesday that Markus is scheduled to begin the role on Jan. 31.
Markus previously worked at biotechnology company Amgen for 13 years in various roles, including vice president of global development. Most recently, he founded an oncology-focused drug company called Dantari, where he served as chief executive.
Markus succeeds Dimitry Nuyten, who is set to depart the company to pursue other opportunities. In 2023, Nuyten made a base salary of $562,000 and a total compensation of $3.69 billion, according to a filing from the company.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
January 21, 2025 16:43 ET (21:43 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。